Gevo, Inc. filings document the company’s renewable-fuels business, Nasdaq-listed common stock, operating results and material corporate events. Form 8-K reports include quarterly and annual financial results, business updates for low-carbon ethanol, carbon management, synthetic aviation fuel initiatives, and material financing or refinancing arrangements involving company subsidiaries.
Proxy and governance filings cover director elections, board composition, auditor ratification, executive compensation votes and officer transitions. The filing record also documents credit agreements, working-capital facilities, renewable natural gas project debt matters, compensatory arrangements and other disclosures related to Gevo’s capital structure, governance and project-development strategy.
Gevo, Inc. (GEVO) reported third-quarter 2026 revenue of $82.953 million, compared with $42.710 million a year earlier, and net income attributable to Gevo of $22.714 million, versus a $7.954 million loss. For the first nine months, revenue was $172.402 million and net loss attributable to Gevo was $175.924 million, compared with a $27.538 million loss; operating cash flow was $12.025 million provided, versus $33.356 million used.
The nine-month results included a $135.788 million noncash impairment charge and a $40.282 million allowance for credit losses on refundable deposits. Following a strategic review, Gevo prioritized its ethanol platform and 30 MMGPY ATJ-30 sustainable aviation fuel project and stopped advancing ATJ-60, other ATJ and certain isobutanol projects. Cash and cash equivalents were $67.554 million at September 30, 2026. A February amendment increased term-loan commitments to $175.0 million; incremental proceeds redeemed the remaining Remarketed Bonds and Series 2025A Bonds. The term loan bears 12.00% interest and matures in January 2030.
Gevo, Inc. (GEVO) reported third-quarter 2026 revenue of $82.953 million, versus $42.710 million a year earlier, and net income attributable to Gevo of $22.714 million, compared with a $7.954 million loss. Adjusted EBITDA, a non-GAAP measure, was $44.121 million versus $6.713 million. Cash flow from operations was $41 million for the quarter, and cash and cash equivalents were $67.554 million as of September 30, 2026.
For the first nine months, Gevo recorded a consolidated net loss of $172.543 million, including $135.788 million in impairment of long-lived assets; operating cash flow was $12.025 million. It expects 2026 Adjusted EBITDA greater than $90 million and 2027 Adjusted EBITDA greater than $70 million. The outlook includes approximately $20 million of non-recurring banked Canadian CFR credit revenue recognized in the third quarter. Gevo expects recent 45ZCF GREET changes to create more than $10 million of annual 45Z value to gross profit from existing RNG assets, subject to third-party validation.
Gevo expects 2026 carbon-business revenue greater than $50 million and reported contracted sales of $70 million in Section 45Z tax credits. The North Dakota debottlenecking project remains on track for completion by year-end 2026, with low-carbon ethanol nameplate capacity expected to reach approximately 75 million gallons per year.
Gevo, Inc. (GEVO) is the issuer in a Schedule 13G reporting that State Street Corporation beneficially owned 10,438,021 shares of its common stock, or 4.2%, for the September 30, 2026 event date. State Street reported shared voting power over 10,175,484 shares and shared dispositive power over 10,438,021 shares, with zero sole voting or dispositive power. It identified SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, and State Street Global Advisors Trust Company as subsidiaries.
Gevo, Inc. common stock: BlackRock, Inc. reported beneficial ownership of 26,793,922 shares, or 10.8% of the class. BlackRock reported sole voting power over 26,312,910 shares and sole dispositive power over 26,793,922 shares, with no shared voting or dispositive power. The reported ownership reflects certain BlackRock business units and subsidiaries and affiliates; other business units disaggregated under SEC guidance are excluded. Various persons have rights to dividends or sale proceeds, but no one person’s interest is more than 5% of the outstanding common shares.
Gevo, Inc. appointed K’Lynne Johnson as a Class II director, effective November 4, 2026. Her current term expires at the annual meeting of stockholders in 2027. Gevo concluded that Johnson is independent under applicable Nasdaq standards.
For her service as a non-employee director, Johnson will receive an annual cash retainer of $85,000 and an equity grant valued at $63,000, subject to the company’s compensation policy. The equity award will be made under Gevo’s Amended and Restated 2010 Stock Incentive Plan. Johnson brings more than three decades of experience and was founder and former President and Chief Executive Officer of Elevance Renewable Sciences.
Gevo, Inc. (GEVO) reports that Chief of Staff Kimberly T. Bowron sold 1,221 shares of common stock on September 3, 2026 at a weighted average price of about $1.71 per share to cover withholding obligations upon vesting of a restricted stock award, with the sales effected under a Rule 10b5-1 trading plan adopted on November 20, 2025. After this sale, she holds 684,817 shares directly and 14,957.39 shares indirectly through a 401(k) plan, where a total of 5.14 shares were disposed of between August 6, 2026 and September 3, 2026 to cover plan administrative fees.
Gevo, Inc. (GEVO) reported that CEO and director Paul D. Bloom sold 1,514 shares of common stock on September 3, 2026 at a weighted average price of $1.7099 per share to cover tax withholding obligations upon vesting of a restricted stock award. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on December 22, 2025. After these transactions, Bloom holds 1,500,789 shares directly and 28,092.13 shares indirectly through a 401(k) plan, which previously disposed of 9.7 shares between August 13 and September 3, 2026 to cover administrative fees.
Gevo, Inc. (GEVO) director Patrick R. Gruber reported selling 3,333 shares of common stock on September 3, 2026 at a weighted average price of $1.7016 per share in an open-market transaction. The sale was made under a Rule 10b5-1 trading plan adopted on March 10, 2026.
After this sale, Gruber holds 3,320,455 shares directly and 25,728.66 shares indirectly through a 401(k) plan, according to a plan statement dated August 25, 2026. The footnotes note small 401(k) disposals of 9.04 shares to cover administrative fees between August 6 and September 3, 2026.
Gevo, Inc. officer Ryan Christopher Michael reported that 1,519 common shares are to be sold, with an aggregate market value of $2,597.34 and an approximate sale date of September 3, 2026. A Rule 10b5-1 plan adoption or instruction date of November 19, 2025 is reported.
The securities information lists 3,333 common shares acquired from the issuer as restricted stock awards on September 1, 2024. The past-three-months table separately names Christopher Ryan and lists sales of 35,196 shares on June 12, 2026, and 39,957 shares on August 6, 2026.
Gevo, Inc. (GEVO) director Patrick R. Gruber has filed a notice under Rule 144 to potentially sell 3,333 shares of Gevo common stock on or after September 3, 2026, through Stifel Nicolaus, with an indicated aggregate market value of $5,671.43 on Nasdaq.
The shares to be sold were issued as restricted stock awards on September 1, 2024 as equity compensation from Gevo. The filing also lists prior sales by Patrick Gruber during the past three months: 157,563 shares for $220,855.00 on June 12, 2026 and 247,642 shares for $373,415.00 on August 6, 2026.